Dimethyl Fumarate Tablet Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 30 mg ,120 mg
Reference Brands: Skilarence (EU)
Category:
Multiple sclerosis
Capsule is a medicine that contains the active substance dimethyl fumarate. It is used to treat relapsing-remitting multiple sclerosis (MS) in adult patients. MS is a chronic disorder that can affect your spinal cord, brain, and optic nerves in the eyes. Relapsing-remitting MS is characterized by repeated attacks of symptoms.
DIMETHYL FUMARATE Tablet is available in Tablets
and strengths such as 30 mg ,120 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, DIMETHYL FUMARATE Tablet is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
DIMETHYL FUMARATE Tablet can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Symptoms vary from person to person but typically include walking difficulties, feeling off-balance and visual difficulties (e.g., blurred or double vision). Before taking this medication, you need to inform your physician if you have kidney disorders, liver disorders, gastrointestinal problems, brain or other infections. This medication is not recommended for adolescents and children.
Dimethyl fumarate (DMF) is a methyl ester of fumaric acid with potent immunomodulatory properties, making it a versatile therapy for both neurological and dermatological conditions. It is designed to modulate immune system activity without causing significant immunosuppression, offering therapeutic benefits while maintaining safety.
In neurology, dimethyl fumarate is approved in the United States under the brand name Tecfidera for the treatment of adults with relapsing forms of multiple sclerosis (MS). It helps reduce relapse frequency and slows the progression of disability in patients with relapsing-remitting MS.
In dermatology, dimethyl fumarate is used in the management of moderate-to-severe plaque psoriasis. In the European Union, it is marketed as Skilarence, while in Germany, DMF combined with other fumaric acid esters is licensed as Fumaderm. These therapies modulate inflammatory responses in the skin and provide an effective treatment option for patients with psoriasis.
Dimethyl fumarate is available as oral formulations in various strengths, depending on the market and indication. Its unique mechanism of action, combined with an established safety profile, makes it a valuable option for patients requiring long-term management of autoimmune or inflammatory conditions.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing